We have developed a new brand and website for AAVantgarde Bio to support the Italian headquartered clinical-stage biotechnology company's next phase of growth and development.
Having successfully closed Series A fundraising in mid-2023, we were commissioned to support AAVantgarde's next stage growth plans with a brand refresh, roll-out and website design and build programme. To align with the pace of AAVantagrde's operational development and scale-up plans, we adopted a sprint-based methodology, developing a phase one website on the Umbraco .NET CMS, in readiness for ongoing module design and development as required.
You can read the full AAVantgarde project case study within our work portfolio.